The Effect of Leucine-Enriched Essential Amino Acid Supplementation on Anabolic and Catabolic Signaling in Human Skeletal Muscle after Acute Resistance Exercise: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Aug 2020
Historique:
received: 24 06 2020
revised: 28 07 2020
accepted: 03 08 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 17 3 2021
Statut: epublish

Résumé

Resistance exercise transiently activates anabolic and catabolic systems in skeletal muscle. Leucine-enriched essential amino acids (LEAAs) are reported to stimulate the muscle anabolic response at a lower dose than whey protein. However, little is known regarding the effect of LEAA supplementation on the resistance exercise-induced responses of the anabolic and catabolic systems. Here, we conducted a randomized, double-blind, placebo-controlled, parallel-group comparison trial to investigate the effect of LEAA supplementation on mechanistic target of rapamycin complex 1 (mTORC1), the ubiquitin-proteasome system and inflammatory cytokines after a single bout of resistance exercise in young men. A total of 20 healthy young male subjects were supplemented with either 5 g of LEAA or placebo, and then they performed 10 reps in three sets of leg extensions and leg curls (70% one-repetition maximum). LEAA supplementation augmented the phosphorylation of mTOR

Identifiants

pubmed: 32806711
pii: nu12082421
doi: 10.3390/nu12082421
pmc: PMC7468954
pii:
doi:

Substances chimiques

Amino Acids, Essential 0
Cytokines 0
IL1B protein, human 0
IL6 protein, human 0
Interleukin-1beta 0
Interleukin-6 0
Muscle Proteins 0
RNA, Messenger 0
Tripartite Motif Proteins 0
FBXO32 protein, human EC 2.3.2.27
SKP Cullin F-Box Protein Ligases EC 2.3.2.27
TRIM63 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Leucine GMW67QNF9C

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ajinomoto Co., Inc.
ID : Not applicable

Références

Cell. 2004 Oct 15;119(2):285-98
pubmed: 15479644
J Nutr. 2011 May;141(5):856-62
pubmed: 21430254
FASEB J. 2011 Nov;25(11):3790-802
pubmed: 21764995
Sports Med. 2015 Jun;45(6):801-7
pubmed: 25739559
Am J Physiol Cell Physiol. 2016 Jun 1;310(11):C874-84
pubmed: 27053525
J Physiol. 2012 Jun 1;590(11):2751-65
pubmed: 22451437
FASEB J. 2019 Mar;33(3):4021-4034
pubmed: 30509128
Amino Acids. 2010 May;38(5):1533-9
pubmed: 19882215
Int J Sport Nutr Exerc Metab. 2010 Jun;20(3):236-44
pubmed: 20601741
J Nutr. 2006 Jan;136(1 Suppl):264S-8S
pubmed: 16365095
J Physiol. 2006 Oct 15;576(Pt 2):613-24
pubmed: 16873412
Sci Rep. 2016 Aug 09;6:31142
pubmed: 27502839
Exerc Immunol Rev. 2005;11:64-85
pubmed: 16385845
Am J Physiol Endocrinol Metab. 2015 Sep 1;309(5):E450-7
pubmed: 26152764
J Appl Physiol (1985). 2007 Nov;103(5):1744-51
pubmed: 17823296
J Physiol. 2016 Jan 15;594(2):453-68
pubmed: 26548696
Amino Acids. 2016 Sep;48(9):2145-55
pubmed: 27168073
Am J Physiol. 1997 Jul;273(1 Pt 1):E99-107
pubmed: 9252485
J Nutr. 2014 Nov;144(11):1694-702
pubmed: 25332468
Nat Cell Biol. 2001 Nov;3(11):1014-9
pubmed: 11715023
Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E791-E801
pubmed: 27624100
Physiol Genomics. 2016 Jan;48(1):21-32
pubmed: 26508702
Am J Physiol Regul Integr Comp Physiol. 2012 Mar 15;302(6):R667-73
pubmed: 22189669
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Aug 15;998-999:88-96
pubmed: 26186723
Biochem Biophys Res Commun. 2019 Nov 26;520(1):73-78
pubmed: 31582215
Eur J Appl Physiol. 2009 Nov;107(4):463-71
pubmed: 19669788
Med Sci Sports Exerc. 2009 Jan;41(1):144-54
pubmed: 19092695
Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1056-65
pubmed: 25827594
FASEB J. 2011 Jan;25(1):99-110
pubmed: 20826541
Rapid Commun Mass Spectrom. 2009 May;23(10):1483-92
pubmed: 19350529
Clin Nutr. 2018 Dec;37(6 Pt A):2011-2021
pubmed: 29031484
Physiol Genomics. 2016 Apr;48(4):320-4
pubmed: 26850043
Int J Food Sci Nutr. 2017 May;68(3):257-264
pubmed: 27653283
J Sports Med Phys Fitness. 2009 Dec;49(4):424-31
pubmed: 20087302
Muscle Nerve. 2010 Jun;41(6):800-8
pubmed: 20082419
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
FASEB J. 2018 May 14;:fj201701422R
pubmed: 29757673
J Cell Biol. 2009 Jun 15;185(6):1083-95
pubmed: 19506036
Front Physiol. 2015 Sep 03;6:245
pubmed: 26388782
Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S52-69
pubmed: 12409811
Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E510-21
pubmed: 22127230
Cell Metab. 2007 Nov;6(5):376-85
pubmed: 17983583
J Physiol. 2013 Jun 1;591(11):2911-23
pubmed: 23551944
Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E43-51
pubmed: 17971512
Food Funct. 2019 May 22;10(5):2766-2773
pubmed: 31041966
J Physiol. 2009 Apr 1;587(Pt 7):1535-46
pubmed: 19188252
J Gerontol A Biol Sci Med Sci. 2013 May;68(5):599-607
pubmed: 23089333
Br J Sports Med. 2018 Mar;52(6):376-384
pubmed: 28698222

Auteurs

Junya Takegaki (J)

Ritsumeikan Global Innovation Research Organization, Ritsumeikan University, Kusatsu, 525-8577, Japan.

Kohei Sase (K)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, 525-8577, Japan.

Jun Yasuda (J)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, 525-8577, Japan.

Daichi Shindo (D)

Ajinomoto Co., Inc., Tokyo 104-8315, Japan.

Hiroyuki Kato (H)

Ajinomoto Co., Inc., Tokyo 104-8315, Japan.

Sakiko Toyoda (S)

Ajinomoto Co., Inc., Tokyo 104-8315, Japan.

Toshiyuki Yamada (T)

Ajinomoto Co., Inc., Tokyo 104-8315, Japan.

Yasushi Shinohara (Y)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, 525-8577, Japan.

Satoshi Fujita (S)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, 525-8577, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH